David Pallister 888 554 5885 dpallister@b-psystems.com


Mark Walkush 888 554 5885 mwalkush@b-psystems.com

BioPharma Systems, LLC can help provide informed solutions to your Pharmaceutical and BioTech processing applications.

BioPharma Systems, headed by David Pallister and Mark Walkush provides high quality technical and commercial support to our North American client base and Global principal vendors across a variety of Pharmaceutical and Biotech arenas including: containment, aseptic processing, laminar flow/clean air technology, sterilization and filling systems.


The combined 40+ years experience in technical sales, innovative design solutions, commercial awareness, sourcing and project support provide much needed confidence for our principal vendors and customers of a strong effective collaboration throughout the equipment selection and project delivery process.


Our expertise reaches across areas such as;
  • Containment solutions including isolators and airflow protection.
  • Aseptic isolator processing solutions.
  • Laminar flow systems.
  • BioSafety Cabinets.
  • VHP, steam and dry heat sterilization products.
  • Custom aseptic filling and handling equipment including Vials, syringes and IV bags.
  • cGMP architectural products including pass thru hatches, doors and vision panels.
  • Drum and IBC handling equipment.

Today, as in the past, we are helping our global customers and principal vendors in the Pharmaceutical, Nanotechnology, BioTech and other specialty health care industries reach new heights. We are dedicated in providing our customers a competitive advantage through intelligent application of our wide range of containment, materials handling and aseptic processing technologies to increase yields and streamline processes. With BioPharma Systems, you will have a team of innovative thinkers and experts to help your business grow and because of our allegiance and dedication to the products we support and supply, our optimism is high for growth across all of our market segments both now and in the near term future.